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MANUAL INTRACARDIAC ELECTROGRAM 
METHOD IS ACCURATE ALTERNATIVE TO 
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SUMMARY – Some manufacturers do not provide automated intracardiac electrogram method 
(IEGM) systems for atrioventricular (AV) and interventricular (VV) delay optimization in cardiac 
resynchronization therapy (CRT). We aimed to evaluate the accuracy of manual IEGM method in 48 
patients previously implanted with Medtronic Syncra CRT. All patients underwent standard device 
interrogation followed by CRT optimization by IEGM method and by echocardiography one month 
after implantation. Th e patient mean age was 60.7±11.8 years and there were 33 (68.8%) males. After 
CRT implantation, the left ventricular ejection fraction increased from 28.0±7.9% to 39.1±11.0% 
(p<0.001). Optimal aortic fl ow Velocity Time Integral (aVTI) was obtained when VV was set to 20-50 
ms left ventricular pre-activation. Th ere was a strong correlation between VV values determined by 
echocardiography and IEGM (R=0.823, p<0.001). We found no signifi cant diff erence in AV, VV and 
aVTI values between echocardiography and IEGM method. However, IEGM was signifi cantly less 
time-consuming than echocardiography [20 (10-28) vs. 40 (35-60) minutes, p<0.001]. Manual IEGM 
method may be good alternative to echocardiography and automated IEGM method. It also empha-
sizes the need for implementation of automated IEGM systems in as many CRT devices as possible.
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Introduction
In refractory congestive heart failure (CHF) ac-
companied by left bundle branch block (LBBB), car-
diac resynchronization therapy (CRT) with biventric-
ular pacing has been shown to be associated with bet-
ter outcomes and has been established as an adjunctive 
heart failure treatment1-3. It has been shown in multi-
center studies that CRT reduces mortality, and im-
proves exercise tolerance and quality of life4-6.
Sequential ventricular pacing can increase mechan-
ical effi  ciency, decrease delay in contraction between 
adjacent left ventricular (LV) walls, reduce mitral 
 regurgitation7,8, and increase ejection fraction (EF). 
However, up to 30% of patients who underwent CRT 
implantation show no improvement. Th e reasons for 
failure to respond include suboptimal lead placement, 
device programming and/or patient selection. Atrio-
ventricular (AV) delay also has a signifi cant eff ect on 
the hemodynamic performance of cardiac pacing since 
insuffi  cient LV fi lling in diastole leads to a decline in 
cardiac output9. Optimizing the third parameter of 
dyssynchrony, the interventricular (VV) delay, with se-
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quential biventricular pacing compared to simultane-
ous biventricular pacing has also been shown to incre-
mentally improve cardiac function7-12. AV/PV and VV 
delay optimization is not commonly performed in rou-
tine clinical practice despite being one of the program-
mable parameters available. Only those that do not 
show improvement from CRT undergo echocardio-
graphic optimization of their AV and VV intervals due 
to the costs, time constraints, and skill and expertise 
required to perform accurately.
Th e intracardiac electrogram method (IEGM) has 
been designed to calculate optimal AV/PV and VV 
delays during routine device follow-up1. Several stud-
ies have reported diagnostic accuracy of IEGM per-
formed by using the software provided along with St. 
Jude’s devices1,13,14. Such automated IEGM yielded 
similar results as echocardiography for AV and VV op-
timization. However, some CRT device manufacturers 
do not provide automated IEGM systems for AV and 
VV optimization.
Th e aim of this study was to evaluate diagnostic 
accuracy of manual application of IEGM formula 
used by St. Jude’s devices in patients undergoing CRT 
with Medtronic devices and to evaluate whether the 
IEGM of AV/PV and VV delay optimization would 
produce similar hemodynamic results as assessed 
by aortic VTI as a surrogate for stroke volume com-




We included 48 patients previously implanted with 
Medtronic Syncra CRT-P cardiac resynchronization 
therapy devices. All patients at our institution who ful-
fi lled the standard indications for CRT according to 
ESC guidelines at the time of inclusion15 were invited 
to participate in this prospective study, which was ap-
proved by the local research Ethics Committee. Pa-
tients were excluded from IEGM studies if they had 
no intrinsic atrial activity (atrial rate ≤40 bpm); had 
atrial fi brillation at the time of the study testing and 
evaluation; or were unable to provide analyzable echo-
cardiogram images. One month after CRT implanta-
tion, all patients underwent standard device interroga-
tion followed by optimization of the CRT pacemaker 
settings by IEGM and by echocardiography (ECHO). 
Th e study was performed during a single scheduled 
follow up visit. All patients were fi rst programmed, 
utilizing the IEGM, and after that, all patients under-
went ECHO optimization. Th e investigator perform-
ing the ECHO study was blinded to the results of the 
IEGM evaluation.
Th e study was approved by the institutional Review 
Board. Considering human and animal rights, all pro-
cedures followed were in accordance with the ethical 
standards of the responsible committee on human ex-
perimentation (institutional and national) and with 
the Helsinki Declaration of 1975, as revised in 2008.
Methods
Cardiac resynchronization therapy optimization 
using intracardiac electrogram method
Calculation of the optimal sensed AV interval is 
based on atrial intrinsic depolarization (atrial IEGM). 
Th e atrial IEGM (P-wave duration) represents atrial 
conduction time and enables estimation of mitral valve 
closure. Th e algorithm measures the width of the atrial 
IEGM, which is off -set by a factor of 30 ms if the in-
trinsic depolarization is >100 ms, or 60 ms if the in-
trinsic depolarization is <100 ms. Th e off -set enables 
delivery of ventricular pacing after completion of atrial 
mechanical contraction ensuring complete mitral valve 
closure and maximizing preload. Th e optimal paced 
AV delay is calculated as the sum of sensed AV delay 
and the pacing latency of 40 ms16.
Th e IEGM VV delay calculation algorithm is 
based on the hypothesis that during optimal depolar-
ization, two paced wavefronts from the RV and LV 
leads will meet near the interventricular septum. Th e 
VV delay algorithm has two components: the conduc-
tion delay (Δ) and the correction term (ε) (1). Δ repre-
sents diff erence between the time of peak intrinsic ac-
tivation on the LV lead (R
LV







]. ε is diff erence in the inter-ventricular con-
duction delay (IVCD) between two ventricular paced 
propagation waveform time delays. Th e IVCD RL is 
the interventricular conduction delay when the RV 
lead is paced and the delay is sensed at the LV lead, 
while the IVCD LR is estimated when the LV lead is 
paced and the delay represents the time when the sig-
nal is sensed at the RV lead. Furthermore, each cham-
ber is paced after a short AV delay to ensure no fusion 
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occurs. Th e correction term equation is ε = IVCD LR 
- IVCD RL. Th e IEGM optimal VV delay equals 
0.5 (Δ + ε). If measured VV is more than 0, the LV 
is activated fi rst, and if VV is less than 0, the RV is 
activated fi rst. Previous studies showed promise for 
the IEGM since the predicted optimal VV delays 
were linearly correlated with echocardiographic aortic 
VTI1,17-19.
Cardiac resynchronization therapy optimization by 
echocardiography
Atrioventricular optimization
Optimization of the AV and VV intervals was un-
dertaken using Pulse Wave Doppler of the General 
Electric Vivid 7 ultrasound machine. Th e AV interval 
was optimized fi rst since it has been shown to provide 
more hemodynamic benefi t than adjusting the VV in-
terval20. Th e mitral infl ow velocity profi le was obtained 
in apical four-chamber view at the level of mitral valve 
leafl et tips at the sweep speed of 100 mm/s. First mea-
surements were taken with either a very long (200 ms) 
or very short (60 ms) AV interval and the duration of 
the mitral infl ow velocity profi le (EA duration) was 
measured in expiration. Th e AV interval was then ad-
justed in 10 ms decrements/increments, respectively, 
and the EA duration was measured for each AV inter-
val. Th e optimal AV interval was defi ned as the short-
est AV interval that resulted in maximal EA duration, 
thus representing the longest LV fi lling time without 
truncating the A wave of mitral infl ow by the onset of 
ventricular systole21,22.
Interventricular interval optimization
Th e LV outfl ow tract (LVOT) Pulse Wave Dop-
pler velocity profi les were measured in the apical fi ve-
chamber view at the sweep speed of 100 mm/s. Th e 
LVOT VTI was measured in expiration at each VV 
interval ranging from -40 to +40 ms in 10 ms incre-
ments. Only if the optimal LVOT VTI was measured 
at a VV interval of -40 or +40 ms, further measure-
ments of LVOT VTI were performed with 10 ms in-
crements (i.e. at -50 or +50 ms). Th e optimal VV inter-
val was defi ned as the VV interval with highest LVOT 
VTI (a surrogate measure of stroke volume and cardiac 
output). Inter-observer variability was eliminated by 
ensuring all measurements were performed by a single 
senior echocardiographer. Intra-patient variability was 
Table 1. Characteristics of the study population 
(continuous variables expressed as mean ± standard 
deviation and categorical variables expressed as number 
and percentage)
Patient characteristic
Age (years) 60.7±11.8 
Male gender, n (%) 33 (68.8%)
BMI 27.7±3.4 
DM type 2, n (%) 17 (35.4%)
PAD, n (%) 7 (14.6%)
CRI, n (%) 7 (14.6%)
Th erapy, n (%)
Furosemide 43 (89.6%)
Spironolactone 35 (72.9%)
ACE inhibitor 46 (95.8%)








Type of cardiomyopathy, n (%)
dilated 35 (72.9%)
ischemic 10 (20.8)
non-specifi ed 3 (6.3%)
LV ejection fraction (%) 28.0±7.9
LVEDV (mL) 241±84
LVESV (mL) 177±68
QRS duration (ms) 183.5±19.9
Placement of RV electrode, n (%)
RVA 46 (95.8%)
RVS 2 (4.2%)





BMI = body mass index; DM = diabetes mellitus; PAD = peripheral 
artery disease; CRI = chronic renal insuffi  ciency; LV = left ventricle; 
LVEDV = left ventricular end-diastolic volume; LVEDS = left ven-
tricular end-systolic volume; RVA = right ventricular apex; RVS = 
right ventricular septum; PLV = posterolateral vein; MCV = middle 
cardiac vein; AIV = anterior intracardiac vein; PV = posterior vein
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minimized by ensuring measurements were performed 
at end-expiration and the mean of three consecutive 
measurements taken.
Statistical analyses
Patient characteristics were assessed with descrip-
tive statistics presented as mean and standard devia-
tion or median with interquartile range values. Inde-
pendent variables were compared using the Mann-
Whitney test and Fisher exact test, as appropriate. 
Dependent variables were compared using the Wil-
coxon test. All correlations were performed using the 
Spearman’s correlation coeffi  cient. Sample size was 
calculated to be 45, when considering type 1 error (a) 
to be 5% and type 2 error (b) to be 20%. Statistical 
analyses were performed using STATISTICA, ver. 
6.0. Th e value of p<0.05 was considered signifi cant.
Results
Th e mean patient age was 60.7±11.8 years and 
there were 33 (68.8%) males. Th e remaining charac-
teristics of the study population are presented in Table 
1. After CRT implantation, EF increased from 
28.0±7.9% to 39.1±11.0%, LVEDV decreased from 
241±84 mL to 189±80 mL, and LVESV decreased 
from 177±68 mL to 121±64 mL (p<0.001 all). Opti-
mal aortic VTI was obtained when VV was set to 20-
50 ms left ventricular pre-activation. Th e distribution 
of VV determined by echocardiography or IEGM was 
similar (Fig. 1). Moreover, we found no signifi cant dif-
ference in sensed atrioventricular interval (SAV), 
paced atrioventricular interval (PAV), VTI and VV 
values between echocardiography and IEGM. How-
ever, IEGM was signifi cantly less time-consuming 
(Table 2). Th ere was a strong correlation between VV 
values determined by echocardiography and IEGM 
(ρ=0.823, p<0.001) (Fig. 2). We also found similar 
positive correlations between PAV and SAV values 
 determined by echocardiography and IEGM, but 
this correlation was substantially weaker (ρ=0.477, 
p<0.001).
Fig. 1. Number of patients in each interventricular delay 
(VV) interval determined by echocardiography (ECHO) 
and intracardiac electrogram method (IEGM).
Fig. 2. Correlation between optimal interventricular 
delay (VV) determined by echocardiography and 
intracardiac electrogram method (IEGM).
Table 2. Diff erence in LVOT, SAV, PAV, optimal VV 
and time between ECHO and IEGM
ECHO IEGM p*
LVOT (cm) 17.2 (6.8-25.6) 17.2 (6.4-25.1) 0.2432
SAV (ms) 100 (70-120) 100 (90-120) 0.0953
PAV (ms) 140 (110-160) 140 (130-160) 0.0953
VV (ms) 40 (10-80) 45 (10-80) 0.3613
Time (min) 40 (35-60) 20 (10-28) <0.001
* Mann-Whitney test; LVOT = left ventricular outfl ow tract; SAV 
= sensed atrioventricular delay; PAV = paced atrioventricular delay; 
VV = interventricular delay; ECHO = echocardiography; IEGM = 
intracardiac electrogram method; data presented as median and in-
terquartile range
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Discussion
Th is prospective clinical trial of AV/PV and VV 
delay programming is the fi rst one that compared 
manual IEGM based on St Jude’s CRT (Quick OptTM 
algorithm) pacemakers with standard echocardiogra-
phy optimization method1,18,23,24. Our study is the fi rst 
to show that manual IEGM can be used for VV opti-
mization after CRT implantation, even for devices 
that do not have automated IEGM system. Previous 
studies have shown that IEGM is an accurate alterna-
tive to time-consuming echocardiography techniques 
for VV optimization14,18,23-25. St Jude’s CRT devices 
have automated IEGM systems, which can accurately 
calculate AV and VV delay in one minute. However, 
Medtronic CRT devices do not provide automated 
IEGM system and therefore, echocardiography tech-
niques are the only possibility for AV and VV optimi-
zation. Our study showed that IEGM could be manu-
ally applied using caliper in patients implanted with 
Medtronic CRT devices. Correlation coeffi  cient be-
tween echocardiographic and IEGM determined VV 
interval was somewhat lower than in previous studies 
(R=0.823)1, but VTIs were exactly the same when VV 
interval was estimated with echocardiography or 
IEGM [17.2 (6.8-25.6) vs. 17.2 (6.4-25.1), p=0.243]. 
Although manual IEGM takes a median of 20 (10-
28) minutes, which is substantially longer when com-
pared with automated IEGM, it is still less time-con-
suming than echocardiography [40 (35-60) minutes]. 
Th erefore, we can conclude that manual IEGM is a 
valuable option for AV and VV optimization. How-
ever, we suggest that automated IEGM system be 
implemented by all manufactures of CRT devices.
Th is study confi rmed the effi  cacy of CRT in increas-
ing EF of the left ventricle and decreasing both LVEDV 
and LVESV. Th ese changes were even greater than re-
ported in previous studies, since we enrolled only pa-
tients with substantial QRS prolongation, who obvi-
ously gain substantial benefi t from CRT. Moreover, our 
study demonstrated that AV and VV optimization was 
necessary in patients undergoing CRT, and that further 
eff ort should be made in providing automated IEGM 
system by all CRT device manufacturers.
Th e main limitation of our study was the absence 
of long-term follow-up in patients undergoing CRT. 
Moreover, this was a non-randomized prospective 
study and thus, conclusions regarding diagnostic ac-
curacy of manual IEGM should be interpreted with 
caution. However, our study provided a rationale for 
performing a randomized clinical trial that would 
compare long-term outcomes between patients in 
whom VV optimization performed with manual 
IEGM technique and by echocardiography.
In conclusion, our study indicated that manual 
IEGM could be good alternative to echocardiography 
and automated IEGM. It also emphasized the need 
for implementation of automated IEGM systems by 
all CRT device manufacturers in order to provide bet-
ter understanding of conduction properties and opti-
mal device programmed setting to get best cardiac 
function. Th e IEGM could also be an additional 
method providing faster ECHO optimization.
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Sažetak
PRIMJENA RUČNE METODE INTRAKRDIJALNIH ELEKTROGRAMA 
ODGOVARAJUĆA JE ZAMJENA EHOKARDIOGRAFSKOJ ATRIOVENTRIKULSKOJ 
I INTERVENTRIKULSKOJ OPTIMIZACIJI RESINKRONIZACIJSKOGA ELEKTROSTIMULATORA SRCA
B. Pezo Nikolić, D. Lovrić, J. Ljubas Maček, V. Rešković Lukšić, R. Matasić i J. Šeparović Hanževački
Neki proizvođači nemaju automatski sustav intrakardijalnog elektrokardiograma (IEGM) za atrioventrikulsku (AV) i 
interventrikulsku (VV) optimizaciju u srčanoj resinkronizacijskoj terapiji (CRT). Cilj ovoga istraživanja bio je procijeniti 
točnost ručnog namještanja IEGM kod bolesnika s ugrađenom CRT. U istraživanje je bilo uključeno 48 bolesnika kojima je 
prethodno ugrađen Medtronic Syncra CRT. Jedan mjesec nakon ugradnje svim bolesnicima je učinjena standardna kontrola 
elektrostimulatora, nakon čega je učinjena optimizacija CRT, prvo metodom IEGM, a potom ultrazvučno. Srednja dob 
 bolesnika bila je 60,7±11,8 godina; bila su 33 (68,8%) muškarca. Nakon ugradnje CRT, ejekcijska frakcija lijeve klijetke 
 narasla je s 28,0±7,9% na 39,1±11,0% (p<0,001). Najveći integral brzine protoka nad aortnom valvulom (aVTI) dobiven je 
pri VV intervalu od 20-50 ms lijeve preekscitacije. Utvrđena je snažna korelacija između trajanja VV intervala dobivenog 
ultrazvučno i IEGM (R=0,823, p<0,001). Nismo našli statistički značajnu razliku između vrijednosti AV, VV i aVTI 
 dobivenih ultrazvučno i metodom IEGM. Ipak, metoda IEGM zahtijeva bitno manje vremena od ultrazvučne metode [20 
(10-28) prema 40 (35- 60) minuta, p<0,001]. Naše istraživanje pokazuje da ručna metoda IEGM može biti dobra alterna tiva 
ehokardiografskoj optimizaciji i automatskoj metodi IEGM. Također ukazuje na potrebu omogućavanja automatske IEGM 
optimizacije kod što više CRT uređaja.
Ključne riječi: Intrakardijalni elektrogram; Optimizacija; Srčana resinkronizacijska terapija; Atrioventrikulski interval; Inter-
ventrikulski interval
